Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference
28 Septembre 2020 - 2:00PM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing
company focused on developing curative therapeutics using
CRISPR/Cas9 technology both in vivo and ex vivo, will present at
Chardan’s Virtual 4th Annual Genetic Medicines Conference on
Monday, October 5, 2020 at 9 a.m. ET.
A live webcast of Intellia’s presentation will be
accessible through the Events and Presentations page of the
Investors & Media section of the company’s website at
www.intelliatx.com. To access the webcast, please log on
approximately 15 minutes prior to the start time, to ensure
adequate time for any software downloads that may be required. A
replay of the webcast will be available on Intellia’s website for
approximately 14 days following the live event. About
Intellia TherapeuticsIntellia Therapeutics is a leading
genome editing company focused on developing proprietary, curative
therapeutics using the CRISPR/Cas9 system. Intellia believes the
CRISPR/Cas9 technology has the potential to transform medicine by
permanently editing disease-associated genes in the human body with
a single treatment course, and through improved cell therapies that
can treat cancer and immunological diseases, or can replace
patients’ diseased cells. The combination of deep scientific,
technical and clinical development experience, along with its
leading intellectual property portfolio, puts Intellia in a unique
position to unlock broad therapeutic applications of the
CRISPR/Cas9 technology and create a new class of therapeutic
products. Learn more about Intellia Therapeutics and CRISPR/Cas9 at
intelliatx.com and follow us on Twitter @intelliatweets.
Intellia Contacts:
Investors:Lina LiAssociate DirectorInvestor
Relations+1 857-706-1612lina.li@intelliatx.com
Media:Jennifer Mound SmoterSenior Vice
PresidentExternal Affairs & Communications+1
857-706-1071jenn.smoter@intelliatx.com
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024